Live feed08:30:00·1968dPRReleasevia QuantisnowViracta Therapeutics Announces Presentation of Updated Phase 2 Data at ASH 2020 and Productive Outcome of its Recent End of Phase 2 Meeting with the FDAByQuantisnow·Wall Street's wire, on your screen.SNSS· Sunesis Pharmaceuticals, Inc.Health CareOriginal source
